Saccharin vs Acesulfame Potassium: which is worse?

What is Saccharin?

Saccharin is the oldest artificial sweetener, discovered accidentally at Johns Hopkins in 1879. It is a sulfonamide compound approximately 300-400 times sweeter than sucrose with no caloric value. It has a slightly bitter metallic aftertaste at higher concentrations. Saccharin's sodium salt (sodium saccharin) is the form used in most food applications.

What is Acesulfame Potassium?

Acesulfame potassium (Ace-K) is a calorie-free synthetic sweetener approximately 200 times sweeter than sucrose. It contains a potassium atom bonded to an oxathiazinone dioxide ring structure. It is heat-stable and non-metabolized, passing through the body unchanged. Often blended with sucralose or aspartame to mask bitter aftertaste.

Documented risks

Saccharin: Saccharin's carcinogenicity history is one of the most tumultuous in food regulatory history. In 1977, the FDA proposed banning saccharin after studies found it caused bladder cancer in rats at very high doses. Congress passed the Saccharin Study and Labeling Act, which put a moratorium on the ban and required a cancer warning label on saccharin products ('Use of this product may be hazardous to your health. This product contains saccharin which has been determined to cause cancer in laboratory animals.'). By 2000, saccharin was removed from the US National Toxicology Program's Report on Carcinogens after subsequent research determined that the bladder cancer in male rats was caused by a rat-specific mechanism — high pH, high protein, and calcium phosphate in rat urine — that does not apply to human urine. The cancer warning label requirement was repealed. IARC also removed saccharin from its Group 2B list in 1999. However, Canada maintained its ban on food use saccharin, citing continued precautionary concern. A 2022 study in Cell found saccharin was among the artificial sweeteners most significantly altering gut microbiome composition and glucose tolerance in previously non-sweetener-using participants. Saccharin showed the largest effect on glucose tolerance among the sweeteners studied (saccharin, sucralose, aspartame, stevia). Saccharin passes through the placenta and appears in breast milk, raising questions about infant exposure that have not been fully resolved.

Acesulfame Potassium: The safety database for Ace-K is considered less comprehensive than that for other sweeteners. Critics have argued that the original FDA approval studies from the 1970s-1980s were insufficient in quality and length to definitively establish long-term safety. The Center for Science in the Public Interest (CSPI) has petitioned for additional testing. Two rat studies found statistically significant increases in lung tumors (in male rats) and mammary tumors at high doses. Regulatory agencies have argued these doses far exceeded typical human exposure and attributed the tumor findings to other factors. However, the question of whether Ace-K's approval studies meet modern standards has been raised by independent researchers. A 2021 study in Cell found that Ace-K and other non-nutritive sweeteners altered gut microbiome composition and affected glucose tolerance in some human participants. Ace-K specifically was associated with changes in gut bacteria that correlated with glycemic effects. Neurological concerns: some animal studies suggest Ace-K may affect brain neurotransmitter systems. A 2013 study in PLoS ONE found that Ace-K consumption in pregnant mice altered offspring postnatal taste preference and increased weight gain, suggesting potential transgenerational effects. These findings were at doses exceeding typical human intake. Endocrine disruption potential has been raised in some in vitro studies, but comprehensive human data are lacking.